<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Molecular Biology</journal-id><journal-title-group><journal-title xml:lang="en">Molecular Biology</journal-title><trans-title-group xml:lang="ru"><trans-title>Молекулярная биология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0026-8984</issn><issn publication-format="electronic">3034-5553</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">699678</article-id><article-id pub-id-type="doi">10.7868/S3034555325060061</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>МОЛЕКУЛЯРНАЯ БИОЛОГИЯ КЛЕТКИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Effect of the Histone Lysine Methyltransferase G9a Inhibitor on the Lifespan and Radioresistance of <italic>Drosophila melanogaster</italic></article-title><trans-title-group xml:lang="ru"><trans-title>ВЛИЯНИЕ ИНГИБИТОРА ГИСТОН-ЛИЗИН-МЕТИЛТРАНСФЕРАЗЫ G9a НА ПРОДОЛЖИТЕЛЬНОСТЬ ЖИЗНИ И РАДИОУСТОЙЧИВОСТЬ <italic>Drosophila melanogaster</italic></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Timusheva</surname><given-names>N. S</given-names></name><name xml:lang="ru"><surname>Тимушева</surname><given-names>Н. С</given-names></name></name-alternatives><email>proshkina.e.n@ib.komisc.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shaposhnikov</surname><given-names>M. V</given-names></name><name xml:lang="ru"><surname>Шапошников</surname><given-names>М. В</given-names></name></name-alternatives><email>proshkina.e.n@ib.komisc.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Proshkina</surname><given-names>E. N</given-names></name><name xml:lang="ru"><surname>Прошкина</surname><given-names>Е. Н</given-names></name></name-alternatives><email>proshkina.e.n@ib.komisc.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Moskalev</surname><given-names>A. A</given-names></name><name xml:lang="ru"><surname>Москалев</surname><given-names>А. А</given-names></name></name-alternatives><email>amoskalev@list.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Biology, Komi Science Centre, Ural Branch, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт биологии Коми научного центра Уральского отделения Российской академии наук</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Longevity with a Clinic of Rehabilitation and Preventive Medicine, Russian Scientific Centre of Surgery named after Academician B.V. Petrovsky</institution></aff><aff><institution xml:lang="ru">Институт долголетия с клиникой реабилитации и превентивной медицины Российского научного центра хирургии им. академика Б.В. Петровского</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-12-25" publication-format="electronic"><day>25</day><month>12</month><year>2025</year></pub-date><volume>59</volume><issue>6</issue><issue-title xml:lang="en">VOL 59, NO6 (2025)</issue-title><issue-title xml:lang="ru">ТОМ 59, №6 (2025)</issue-title><fpage>957</fpage><lpage>970</lpage><history><date date-type="received" iso-8601-date="2025-12-27"><day>27</day><month>12</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Российская академия наук</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-12-25"/></permissions><self-uri xlink:href="https://vietnamjournal.ru/0026-8984/article/view/699678">https://vietnamjournal.ru/0026-8984/article/view/699678</self-uri><abstract xml:lang="en"><p>The enzyme lysine methyltransferase G9a is an important regulator of transcription of various genes and cellular processes, but its role in determining aging and radioresistance of an organism has not been well studied. In this work, the effect of UNC0646, a selective G9a inhibitor, on the lifespan of <italic>Drosophila melanogaster</italic> and its resistance to γ-radiation and paraquat was investigated. UNC0646 at the concentrations of 0.1–100 μM exerted a geroprotective effect on females, causing an increase in the average lifespan by 1.6–13.9% (<italic>p</italic> &lt; 0.05). At the same time, after consuming this substance for two weeks, a decrease in <italic>Drosophila</italic> resistance to γ-radiation was observed. The positive effect of the drug on the lifespan of females may be due to the activation of genes of DNA damage response and repair (<italic>D-Gadd45, mei-9, spn-B, Ku80</italic>) and proteostasis genes (<italic>Hsp27, Hsp68, Atg1, Ire1</italic>).</p></abstract><trans-abstract xml:lang="ru"><p>Гистон-лизин-метилтрансфераза G9a играет важную роль в регуляции транскрипции различных генов и клеточных процессов, однако ее участие в детерминации старения и радиоустойчивости организма недостаточно изучено. В данной работе анализировали влияние селективного ингибитора G9a – UNC0646 – на продолжительность жизни особей <italic>Drosophila melanogaster</italic> и их устойчивость к действию γ-излучения и параквата. UNC0646 в концентрации 0.1–100 мкмоль/л оказывал геропротекторное действие на самок дрозофилы, вызвав увеличение средней продолжительности жизни на 1.6–13.9% (<italic>p</italic> &lt; 0.05). В то же время у дрозофил, получавших UNC0646 в течение 2 недель, наблюдалось снижение устойчивости к γ-излучению. Положительное влияние UNC0646 на продолжительность жизни самок может быть обусловлено активацией генов ответа на повреждение ДНК и репарации ДНК (<italic>D-Gadd45, mei-9, spn-B, Ku80</italic>) и генов протеостаза (<italic>Hsp27, Hsp68, Atg1, Ire1</italic>).</p></trans-abstract><kwd-group xml:lang="en"><kwd>lifespan</kwd><kwd>stress resistance</kwd><kwd>γ-radiation</kwd><kwd>methyltransferase G9a</kwd><kwd>UNC-0646</kwd><kwd><italic>Drosophila melanogaster</italic></kwd></kwd-group><kwd-group xml:lang="ru"><kwd>продолжительность жизни</kwd><kwd>стрессоустойчивость</kwd><kwd>γ-излучение</kwd><kwd>гистон-метилтрансфераза G9a</kwd><kwd>UNC-0646</kwd><kwd><italic>Drosophila melanogaster</italic></kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследования выполнены в рамках государственного задания по теме “Генетические механизмы стрессоустойчивости и контроля продолжительности жизни для поиска новых мишеней для геропротекторных вмешательств на модели Drosophila melanogaster” (№ 125013101228-2).</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Прошкина Е.Н., Соловьёв И.А., Шапошников М.В., Москалев А.А. (2020) Ключевые молекулярные механизмы старения, биомаркеры и потенциальные интервенции. Молекуляр. биология. 54, 883–921.</mixed-citation><mixed-citation xml:lang="kk">Прошкина Е.Н., Соловьёв И.А., Шапошников М.В., Москалев А.А. (2020) Ключевые молекулярные механизмы старения, биомаркеры и потенциальные интервенции. Молекуляр. биология. 54, 883–921.</mixed-citation><mixed-citation xml:lang="pt">Прошкина Е.Н., Соловьёв И.А., Шапошников М.В., Москалев А.А. (2020) Ключевые молекулярные механизмы старения, биомаркеры и потенциальные интервенции. Молекуляр. биология. 54, 883–921.</mixed-citation><mixed-citation xml:lang="ru">da Costa J.P., Vitorino R., Silva G.M., Vogel C., Duarte A.C., Rocha-Santos T. (2016) A synopsis on aging-Theories, mechanisms and future prospects. Ageing Res. Rev. 29, 90–112.</mixed-citation><mixed-citation xml:lang="zh">Прошкина Е.Н., Соловьёв И.А., Шапошников М.В., Москалев А.А. (2020) Ключевые молекулярные механизмы старения, биомаркеры и потенциальные интервенции. Молекуляр. биология. 54, 883–921.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><mixed-citation>Прошкина Е.Н., Соловьёв И.А., Шапошников М.В., Москалев А.А. (2020) Ключевые молекулярные механизмы старения, биомаркеры и потенциальные интервенции. Молекуляр. биология. 54, 883–921.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wang K., Liu H., Hu Q., Wang L., Liu J., Zheng Z., Zhang W., Ren J., Zhu F., Liu G.H. (2022) Epigenetic regulation of aging: implications for interventions of aging and diseases. Signal Transduct. Target Ther. 7, 374.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Kouzarides T. (2007) Chromatin modifications and their function. Cell. 128, 693–705.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Zhang Y., Sun Z., Jia J., Du T., Zhang N., Tang Y., Fang Y., Fang D. (2021) Overview of histone modification. Histone Mutations Cancer. 1283, 1–16.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Soto-Palma C., Niedernhofer L.J., Faulk C.D., Dong X. (2022) Epigenetics, DNA damage, and aging. J. Clin. Invest. 132, e158446.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sidler C., Kovalchuk O., Kovalchuk I. (2017) Epigenetic regulation of cellular senescence and aging. Front. Genet. 8, 138.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Shinkai Y., Tachibana M. (2011) H3K9 methyltransferase G9a and the related molecule GLP. Genes. Dev. 25, 781–788.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Poulard C., Noureddine L.M., Pruvost L., Le Romancer M. (2021) Structure, activity, and function of the protein lysine methyltransferase G9a. Life (Basel). 11, 1082.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bellver-Sanchis A., Ribalta-Vilella M., Irisarri A., Gehlot P., Choudhary B.S., Jana A., Vyas V.K., Banerjee D.R., Pallas M., Guerrero A., Grifan-Ferre C. (2025) G9a an epigenetic therapeutic strategy for neurodegenerative conditions: from target discovery to clinical trials. Med. Res. Rev. 45, 985–1015.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bellver-Sanchis A., Geng Q., Navarro G., Avila-López P.A., Companys-Alemany J., Marsal-García L., Larramona-Arcas R., Miró L., Perez-Bosque A., Ortuno-Sahagún D., Banerjee D.R., Choudhary B.S., Soriano F.X., Poulard C., Pallas M., Du H.N., Grifan-Ferre C. (2024) G9a Inhibition promotes neuroprotection through GMFB regulation in Alzheimer's disease. Aging Dis. 15, 311–337.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Wei L., Chiu D.K., Tsang F.H., Law C.T., Cheng C.L., Au S.L., Lee J.M., Wong C.C., Ng I.O., Wong C.M. (2017) Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J. Hepatol. 67, 758–769.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Wang Y.F., Zhang J., Su Y., Shen Y.Y., Jiang D.X., Hou Y.Y., Geng M.Y., Ding J., Chen Y. (2017) G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin. Nat. Commun. 8, 274.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Chen G., Yu X., Zhang M., Zheng A., Wang Z., Zuo Y., Liang Q., Jiang D., Chen Y., Zhao L., Jiang L., Li D., Liao S. (2019) Inhibition of euchromatic histone lysine methyltransferase 2 (EHMT2) suppresses the proliferation and invasion of cervical cancer cells. Cytogenet. Genome Res. 158, 205–212.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ma W., Han C., Zhang J., Song K., Chen W., Kwon H., Wu T. (2020) The histone methyltransferase G9a promotes cholangiocarcinogenesis through regulation of the hippo pathway kinase LATS2 and YAP signaling pathway. Hepatology. 72, 1283–1297.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Dang N.N., Jiao J., Meng X., An Y., Han C., Huang S. (2020). Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway. Aging (Albany NY). 12, 2393–2407.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Zhang X.Y., Rajagopalan D., Chung T.H., Hooi L., Toh T.B., Tian J.S., Rashid M., Sahib N., Gu M., Lim J.J., Wang W., Chng W.J., Jia S., Chow E.K. (2020) Frequent upregulation of G9a promotes ReIB-dependent proliferation and survival in multiple myeloma. Exp. Hematol. Oncol. 9, 8.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Chen P., Qian Q., Zhu Z., Shen X., Yu S., Yu Z., Sun R., Li Y., Guo D., Fan H. (2020) Increased expression of EHMT2 associated with H3K9me2 level contributes to the poor prognosis of gastric cancer. Oncol. Lett. 20, 1734–1742.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Chen H., Yan Y., Davidson T.L., Shinkai Y., Costa M. (2006) Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res. 66, 9009–9016.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kim Y., Kim Y.S., Kim D.E., Lee J.S., Song J.H., Kim H.G., Cho D.H., Jeong S.Y., Jin D.H., Jang S.J., Seol H.S., Suh Y.A., Lee S.J., Kim C.S., Koh J.Y., Hwang J.J. (2013) BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy. 9, 2126–2139.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Liu F., Chen X., Allali-Hassani A., Quinn A.M., Wasney G.A., Dong A., Barsyte D., Kozieradzki I., Senisterra G., Chau I., Siarheyeva A., Kireev D.B., Jadhav A., Herold J.M., Frye S.V., Arrowsmith C.H., Brown P.J., Simeonov A., Vedadi M., Jin J. (2009) Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J. Med. Chem. 52, 7950–7953.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Liu F., Barsyte-Lovejoy D., Allali-Hassani A., He Y., Herold J.M., Chen X., Yates C.M., Frye S.V., Brown P.J., Huang J., Vedadi M., Arrowsmith C.H., Jin J. (2011) Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines. J. Med. Chem. 54, 6139–6150.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Grifan-Ferré C., Marsal-García L., Bellver-Sanchis A., Kondengaden S.M., Turga R.C., Vázquez S., Pallás M. (2019) Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-amyloid plaques in an early-onset Alzheimer's disease mouse model. Aging (Albany NY). 11, 11591–11608.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Cabreiro F., Au C., Leung K.Y., Vergara-Irigaray N., Cochene H.M., Noori T., Weinkove D., Schuster E., Greene N.D., Gems D. (2013) Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 153, 228–239.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Gong H., Qian H., Eril R., Astle C.M., Wang G.G., Harrison D.E., Xu X. (2015) Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain. Oncotarget. 6, 15882–15890.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Hassan F.U., Rehman M.S., Khan M.S., Ali M.A., Javed A., Nawaz A., Yang C. (2019) Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects. Front. Genet. 10, 514.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Tran P.V., Kennedy B.C., Lien Y.C., Simmons R.A., Georgieff M.K. (2015) Fetal iron deficiency induces chromatin remodeling at the BDNF locus in adult rat hippocampus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 308, R276–R282.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Xia B., de Belle J.S. (2016) Transgenerational programming of longevity and reproduction by post-eclosion dietary manipulation in Drosophila. Aging (Albany NY). 8, 1115–1134.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Cvetković V.J.M., Jovanovic T.L., Stamenković B., Todorović S.S., Dordević M., Radulović N.M. (2015) Toxicity of dimethyl sulfoxide against Drosophila melanogaster. Biol Nyssana. 6, 91–95.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Landis G.N., Doherty D., Tower J. (2020) Analysis of Drosophila melanogaster lifespan. Meth. Mol. Biol. 2144, 47–56.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Hilton J.F., Mehta C.R., Patel N.R. (1994) An algorithm for conducting exact Smirnov tests. Comput. Statistics &amp; Data Analysis. 17, 351–361.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Mantel N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163–170.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Han S.K., Kwon H.C., Yang J.S., Kim S., Lee S.V. (2024) OASIS portable: user-friendly offline suite for secure survival analysis. Mol. Cells. 47, 100011.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Wang C., Li Q., Redden D.T., Weindruch R., Allison D.B. (2004) Statistical methods for testing effects on “maximum lifespan”. Mech. Ageing Dev. 125, 629–632.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Yang J.S., Nam H.J., Seo M., Han S.K., Choi Y., Nam H.G., Lee S.J., Kim S. (2011) OASIS: online application for the survival analysis of lifespan assays performed in aging research. PLoS One. 6, e23525.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Patthankar J.G., Decksha K., Patil R.K. (2017) Gamma radiation tolerance in different life stages of the fruit fly Drosophila melanogaster. Int. J. Radiat Biol. 93, 440–448.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Livak K.J., Schmittgen T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>–ΔΔC<sub>T</sub></sup> Method. Methods. 25, 402–408.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Gu M., Toh T.B., Hooi L., Lim J.J., Zhang X., Chow E.K. (2019) Nanodiamond-mediated delivery of a G9a inhibitor for hepatocellular carcinoma therapy. ACS Appl. Mater. Interfaces. 11, 45427–45441.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Mis J., Ner S.S., Grigliatti T.A. (2006) Identification of three histone methyltransferases in Drosophila: dG9a is a suppressor of PEV and is required for gene silencing. Mol. Genet. Genomics. 275, 513–526.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Jang J.E., Eom J.-I., Jeung H.-K., Chung H., Kim Y.R., Kim J.S., Cheong J.-W., Min Y.H. (2020) PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells. J. Exp. Clin. Cancer Res. 39, 66.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Yang Q., Zhu Q., Lu X., Du Y., Cao L., Shen C., Hou T., Li M., Li Z., Liu C., Wu D., Xu X., Wang L., Wang H., Zhao Y., Yang Y., Zhu W.G. (2017) G9a coordinates with the RPA complex to promote DNA damage repair and cell survival. Proc. Natl. Acad. Sci. USA. 114, E6054–E6063.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Feng T., Wang H., Zhang X., Sun H., You Q. (2014) The discovery of novel histone lysine methyltransferase G9a inhibitors (part I): molecular design based on a series of substituted 2,4-diamino-7-aminoalkoxyquinazoline by molecular-docking-guided 3D quantitative structure-activity relationship studies. Med. Chem. 10, 426–440.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Chae Y.C., Kim J.Y., Park J.W., Kim K.B., Oh H., Lee K.H., Seo S.B. (2019) FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer. Nucl. Acids Res. 47, 1692–1705.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Shen J., Curtis C., Tavare S., Tower J. (2009) A screen of apoptosis and senescence regulatory genes for life span effects when over-expressed in Drosophila. Aging (Albany NY). 1, 191–211.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Manola M.S., Gumeni S., Trougakos I.P. (2021) Differential doseand tissue-dependent effects of FOXO on aging, metabolic and proteostatic pathways. Cells. 10, 3577.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Li F., Zeng J., Gao Y., Guan Z., Ma Z., Shi Q., Du C., Jia J., Xu S., Wang X., Chang L., He D., Guo P. (2015) G9a inhibition induces autophagic cell death via AMPK/mTOR pathway in bladder transitional cell carcinoma. PLoS One. 10, e0138390.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Mannick J.B., Lamming D.W. (2023) Targeting the biology of aging with mTOR inhibitors. Nat. Aging. 3, 642–660.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Pattingre S., Espert L., Biard-Piechaczyk M., Codogno P. (2008) Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie. 90, 313–323.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Meares G.P., Hughes K.J., Naatz A., Papa F.R., Urano F., Hansen P.A., Benveniste E.N., Corbett J.A. (2011) IRE1-dependent activation of AMPK in response to nitric oxide. Mol. Cell Biol. 31, 4286–4297.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Bellver-Sanchis A., Ávila-López P.A., Tic I., Valle-García D., Ribalta-Vilella M., Labrador L., Banerjee D.R., Guerrero A., Casadesus G., Poulard C., Pallas M., Griffán-Ferré C. (2024) Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128. Neural. Regen. Res. 19, 2532–2542.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Han J.L.T., Pang K.K.L., Ang S.R.X., Sharma M., Sajikumar S. (2021) Inhibition of lysine methyltransferase G9a/GLP reinstates long-term synaptic plasticity and synaptic tagging/capture by facilitating protein synthesis in the hippocampal CA1 area of APP/PS1 mouse model of Alzheimer's disease. Transl. Neurodegener. 10, 23.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Miller R.A., Harrison D.E., Astle C.M., Fernandez E., Flurkey K., Han M., Javors M.A., Li X., Nadon N.L., Nelson J.F., Pletcher S., Salmon A.B., Sharp Z.D., Van Roekel S., Winkleman L., Strong R. (2014) Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell. 13, 468–477.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Fischer K.E., Gelfond J.A., Soto V.Y., Han C., Someya S., Richardson A., Austad S.N. (2015) Health effects of long-term rapamycin treatment: the impact on mouse health of enteric rapamycin treatment from four months of age throughout life. PLoS One. 10, e0126644.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Aceves-Aparicio E., Pérez-Staples D., Arredondo J., Corona-Morales A., Morales-Mávil J., Díaz-Fleischer F. (2021) Combined effects of methoprene and metformin on reproduction, longevity, and stress resistance in Anastrepha ludens (Diptera: Tephritidae): implications for the sterile insect technique. J. Econ. Entomol. 114, 142–151.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Zhu Y., Engmann M., Medina D., Han X., Das P., Bartke A., Ellsworth B.S., Yuan R. (2024) Metformin treatment of juvenile mice alters aging-related developmental and metabolic phenotypes in sex-dependent and sex-independent manners. Geroscience. 46, 3197–3218.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Brivio E., Lopez J.P., Chen A. (2020) Sex differences: transcriptional signatures of stress exposure in male and female brains. Genes. Brain Behav. 19, e12643.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Shaposhnikov M.V., Zemskaya N.V., Koval L.A., Schegoleva E.V., Zhavoronkov A., Moskalev A.A. (2018) Effects of N-acetyl-L-cysteine on lifespan, locomotor activity and stress-resistance of 3 Drosophila species with different lifespans. Aging (Albany NY). 10, 2428–2458.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Zhikrevetskaya S., Peregudova D., Danilov A., Plyusnina E., Krasnov G., Dmitriev A., Kudryavtseva A., Shaposhnikov M., Moskalev A. (2015) Effect of low doses (5-40 cGy) of gamma-irradiation on lifespan and stress-related genes expression profile in Drosophila melanogaster. PLoS One. 10, e0133840.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Seira O., Wang W., Lee S., Roskams J., Tetzlaff W. (2020) HDAC inhibition leads to age-dependent opposite regenerative effect upon PTEN deletion in rubrospinal axons after SCI. Neurobiol. Aging. 90, 99–109.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Bashir B., Gulati M., Vishwas S., Gupta G., Dhanasekaran M., Paudel K.R., Chellappan D.K., Anand K., Negi P., Singh P.K., Rajput A., Dua K., Singh S.K. (2025) Bridging gap in the treatment of Alzheimer’s disease via postbiotics: current practices and future prospects. Ageing Res. Rev. 105, 102689.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Riahi H., Fenckova M., Goruk K.J., Schenck A., Kramer J.M. (2021) The epigenetic regulator G9a attenuates stress-induced resistance and metabolic transcriptional programs across different stressors and species. BMC Biol. 19, 112.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Poetsch A.R. (2020) The genomics of oxidative DNA damage, repair, and resulting mutagenesis. Comput. Struct. Biotechnol. J. 18, 207–219.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Ginjala V., Rodríguez-Colon L., Ganguly B., Gangidi P., Gallina P., Al-Hraishawi H., Kulkarni A., Tang J., Gheeya J., Simhadri S., Yao M., Xia B., Ganesan S. (2017) Protein-lysine methyltransferases G9a and GLP1 promote responses to DNA damage. Sci. Rep. 7, 16613.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Riahi H., Brekelmans C., Foriel S., Merkling S.H., Lyons T.A., Itskov P.M., Kleefstra T., Ribeiro C., van Rij R.P., Kramer J.M., Schenck A. (2019) The histone methyltransferase G9a regulates tolerance to oxidative stress-induced energy consumption. PLoS Biol. 17, e2006146.</mixed-citation></ref></ref-list></back></article>
